Rhabdomyosarcoma and pleomorphic sarcoma in the same location : Recurrence or new entity?
Radiation-associated soft tissue sarcoma
Radiotherapy
Recurrence
Sarcoma pathology
Soft tissue sarcoma
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
05
02
2021
accepted:
31
03
2021
pubmed:
28
4
2021
medline:
8
2
2022
entrez:
27
4
2021
Statut:
ppublish
Résumé
Soft tissue sarcomas (STS) represent a small group of adult solid malignancies, with risk factors such as environmental factors, genetic predisposition, and prior radiotherapy. In STS patients with a novel swelling, differential diagnoses include recurrence, second primary cancer, metastasis from unknown primary cancer, and radiation-associated STS, the latter usually occurring approximately 10 years after radiotherapy. We present the case of a 64-year-old male patient with pleomorphic rhabdomyosarcoma, who underwent resection and radiotherapy. The patient presented again 5 years later with painful swelling in the area of the prior sarcoma, raising suspicion of recurrence. Resection was performed and a diagnosis of pleomorphic sarcoma (not otherwise specified [NOS]) was made. The patient was treated with radiotherapy and remained sarcoma-free for the following 7 years. A molecular analysis of both neoplasms, using RNA next-generation sequencing, did not detect any specific fusions. Due to the lack of rhabdomyoblastic differentiation in the second sarcoma and the low likelihood of a second primary in the same previously irradiated location, the diagnosis of a radiation-associated STS was suggested. This short report illustrates the difficult diagnostic work-up of a presumably radiation-associated STS, as these neoplasms lack characteristic morphological and immunohistochemical features. In our case, the suggested diagnosis may have pointed against another course of radiotherapy in an already irradiation-harmed region. Therefore, a relatively low latency period between surgery, radiotherapy, and diagnosis of another STS should not automatically point towards recurrence and may prompt further in-depth investigation.
Identifiants
pubmed: 33905030
doi: 10.1007/s00508-021-01872-5
pii: 10.1007/s00508-021-01872-5
pmc: PMC8813824
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
76-79Informations de copyright
© 2021. The Author(s).
Références
J Clin Oncol. 2010 Apr 20;28(12):2064-9
pubmed: 20308666
Cancer. 1948 May;1(1):3-29
pubmed: 18867438
Ann Surg Oncol. 2015 Nov;22(12):3913-20
pubmed: 25743327
Clin Sarcoma Res. 2012 Oct 04;2(1):14
pubmed: 23036164
Am J Surg Pathol. 2016 Apr;40(4):479-89
pubmed: 26645727
Cancer. 1971 Nov;28(5):1087-99
pubmed: 5288429
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402